Nosebleeds are associated with greater risk for postpartum hemorrhage
Women with epistaxis during pregnancy are at increased risk for postpartum hemorrhage, even after controlling for cesarean delivery.
Women with epistaxis during pregnancy are at increased risk for postpartum hemorrhage, even after controlling for cesarean delivery and excluding women with epistaxis before pregnancy.
The findings come from a study involving 1,470 pregnant women and 275 nonpregnant counterparts. About one-fifth (20.3%) of the pregnant women suffered nosebleeds, whereas only 6.2% of those not pregnant did so (P<.001). About one-tenth (10.7%) of the pregnant women with epistaxis suffered postpartum hemorrhage compared with 6.7% of the women without epistaxis (P=.02).
The authors of the study advise that clinicians obtain a careful history of epistaxis to help determine which women are at greatest risk for disordered hemostasis.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More
